Vitamin K2 for adults with episodic migraine
Part of Blood & lymphatic, Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether taking vitamin K2 can reduce the number of migraine days per month. It may help people who have had episodic migraines for at least a year and meet specific migraine frequency and medication requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18 years or older).
- You’ve had episodic migraine (with or without “aura”) for more than 12 months.
- In the last 3 months, you’ve had 4 to 14 migraine days per month, and this is confirmed during the study’s baseline period.
- You kept your migraine diary successfully during the baseline period.
- You are NOT currently taking migraine prevention medicines (like valproate, topiramate, beta-blockers, and others listed), and you haven’t taken them in the last 3 months.
- You can’t have certain other headache types mixed in, and you must avoid frequent migraine/stopping medicines and some other drugs (including triptans/ergot too often, high-use pain relievers, opioids, and anticoagulants).
- You can’t be pregnant or breastfeeding, and you must be able to take pills by mouth; also no vitamin K2 allergy and no known problems absorbing food.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of vitamins and supplements can help prevent migraines. It's for adults who have migraines often (at least 6 days per month) and want to try a non-drug option.
This trial tests whether a special dietary supplement regimen can improve quality of life, work productivity, and certain health markers in adults who have migraines. If you have migraines and are willing to take supplements, this study might help you feel better and may offer a natural option.
This trial tests whether a daily dose of atorvastatin (a common cholesterol medicine) can prevent migraine attacks in people with episodic migraine. You would keep a headache diary and be randomly assigned to take atorvastatin or a placebo for about 3 months.
This trial tests whether the cholesterol drug atorvastatin can reduce the number of migraine days in people with chronic migraine (15 or more headache days per month, including at least 8 migraine days). If you have frequent migraines and haven't tried statins before, this study may offer a new preventive option.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
Hear when a new Arterial Stiffness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.